UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026999
Receipt number R000030956
Scientific Title Multicenter clinical study to evaluate the wear resistance of the BIOCERAM AZUL head in total hip arthroplasty
Date of disclosure of the study information 2017/04/21
Last modified on 2023/04/19 09:19:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter clinical study to evaluate the wear resistance of the BIOCERAM AZUL head in total hip arthroplasty

Acronym

AZUL study

Scientific Title

Multicenter clinical study to evaluate the wear resistance of the BIOCERAM AZUL head in total hip arthroplasty

Scientific Title:Acronym

AZUL study

Region

Japan


Condition

Condition

hip joint disease

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the differances of wear resistance using the BIOCERAM AZUL head between 32mm and 36mm in total hip arthroplasty

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Linear wear of polyethylene liner

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients with an indication for primary THA as for an operative hip, and consented to the operation(both hips surgery possible).
2)Patients suitable for 32mm and 36mm demoral heads.
3)Patients aged from 20 to 75 years at the time of awritten consent, and the consent to participate in this clinical study is obtaioned before THA (Not gender specific).

Key exclusion criteria

1)Patients whose weight is over 90kg, the weight restriction of the femoral components to be used.
2)Patients who are difficult to be followed for 5 years after THA(in cases that emergency treatments are expected during observation period such as patients recieving hemodialylsis and anticancer drug therapies, or patients will move)
3)Patients whose functions of the implanted device are difficult to evaluate due to of other organs such as heart and nervous system.
4)Patients who are evaluated to be unsuitable for subjects of this study by invetigators.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Dai
Middle name
Last name Miyasaka

Organization

Niigata University Medical and Dental Hospital

Division name

Division of Orthpaedic Surgery

Zip code

951-8510

Address

1-754, Asahimachi-dori, Chuo-ku, Niigata City, Niigata prefecture

TEL

025-227-2272

Email

miyasakad@yahoo.co.jp


Public contact

Name of contact person

1st name Dai
Middle name
Last name Miyasaka

Organization

Niigata University Medical and Dental Hospital

Division name

Division of Orthpaedic Surgery

Zip code

951-8510

Address

1-754, Asahimachi-dori, Chuo-ku, Niigata City, Niigata prefecture

TEL

025-227-2272

Homepage URL


Email

miyasakad@yahoo.co.jp


Sponsor or person

Institute

Niigata University Medical and Dental Hospital

Institute

Department

Personal name



Funding Source

Organization

KYOCERA Medical Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University Medical and Dental Hospital

Address

1-754, Asahimachi-dori, Chuo-ku, Niigata City, Niigata prefecture

Tel

025-227-2005

Email

Joho@med.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 12 Month 20 Day

Date of IRB


Anticipated trial start date

2017 Year 04 Month 24 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

-


Management information

Registered date

2017 Year 04 Month 14 Day

Last modified on

2023 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030956


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name